Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL5793232

NNC(=O)c1cc2ccccc2o1.O=C(O)C(F)(F)F

nearest known ligand 0.61

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.61
ALDH1A1 P00352 4/20 0.61
TP53 P04637 3/20 0.61
HPGD P15428 2/20 0.61
NPC1 O15118 5/20 0.60
RAB9A P51151 5/20 0.60
NFKB1 P19838 2/20 0.60
NFKB2 Q00653 2/20 0.60
RELA Q04206 2/20 0.60
PKM P14618 1/20 0.60
MEN1 O00255 2/20 0.58
KMT2A Q03164 2/20 0.58
TSHR P16473 1/20 0.56
MAOB P27338 1/20 0.55
TAS1R3 Q7RTX0 1/20 0.55
TAS1R1 Q7RTX1 1/20 0.55
GALK1 P51570 1/20 0.55
FLT3 P36888 1/20 0.54
KDM4E B2RXH2 1/20 0.54
GAA P10253 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5592854 0.89 TP53 (0.69) SMN1; SMN2ALDH1A1TP53HPGDNPC1
Trifluoroacetic Acid SCHEMBL27846344 0.83 FLT3 (0.59) SMN1; SMN2ALDH1A1TP53HPGDNPC1
Trifluoroacetic Acid SCHEMBL28751252 0.82 FLT3 (0.57) SMN1; SMN2ALDH1A1TP53HPGDNPC1
Tert-Butyl Formate SCHEMBL28177432 0.78 TAS1R3 (0.53) SMN1; SMN2ALDH1A1TP53HPGDNPC1
SCHEMBL4055368 0.78 FLT3 (0.56) SMN1; SMN2ALDH1A1TP53HPGDNPC1
SCHEMBL28891069 0.76 NPC1 (0.68) SMN1; SMN2ALDH1A1TP53HPGDNPC1
SCHEMBL13485789 0.76 NPC1 (0.68) SMN1; SMN2ALDH1A1TP53HPGDNPC1
SCHEMBL11379610 0.76 SMN1; SMN2 (0.73) SMN1; SMN2ALDH1A1TP53HPGDNPC1
SCHEMBL19476629 0.76 TP53 (1.00) SMN1; SMN2ALDH1A1TP53HPGDNPC1
SCHEMBL5866982 0.75 NPC1 (1.00) SMN1; SMN2ALDH1A1TP53HPGDNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006027211-A1 2,4-SUBSTITUTED PYRIMIDINES AS CYSTEINE PROTEASE INHIBITORS GLAXO GROUP LIMITED (GB) 2006-03-16 WO disclosed